A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Covariate-adaptive randomization represents an advanced methodology in the design of clinical trials, ensuring a balanced distribution of prognostic factors among treatment groups. This approach ...
Randomised clinical trials (RCTs) remain the gold standard in evaluating therapeutic interventions, ensuring that treatment effects are not confounded by systematic errors. Central to these trials is ...
"Covariate adjustment" in the randomized trial context refers to an estimator of the average treatment effect that adjusts for chance imbalances between study arms in baseline variables (called ...
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma ...
New findings reveal sotagliflozin's benefits for patients with heart failure with preserved ejection fraction without ...
Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...
MedPage Today on MSN
Hypnosis for Hot Flashes? Clinical Trial Says Yes
In a 2023 position statement, the Menopause Society recommended clinical hypnosis for vasomotor symptoms, and other randomized trials have shown that therapist-delivered hypnosis can reduce the ...
The SOL-R registrational trial (NCT06495918) of OTX-TKI (AXPAXLI) by Ocular Therapeutix has reached its randomization target of 555 patients.
MedPage Today on MSN
Conservative Dialysis Feasible in Acute Kidney Injury, Trial Suggests
HOUSTON -- A conservative dialysis strategy improved rates of kidney function compared to conventional thrice-weekly dialysis in patients with acute kidney injury (AKI) undergoing kidney replacement ...
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 18 June 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results